A Study of Nemtabrutinib vs Chemoimmunotherapy for Participants With Previously Untreated Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma (CLL/SLL) Without TP53 Aberrations (MK-1026-008, BELLWAVE-008)
Clinical trial NCT05624554 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT05624554
- Sponsor
- Merck Sharp & Dohme LLC
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2023-03-16
- Primary completion
- 2027-05-19
- Enrollment
- 300
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.